More SEC Filings
View Older Stories View Newer Stories-
Form 8-K Passage BIO, Inc. For: Mar 04
-
Form 24F-2NT RIVERSOURCE VARIABLE For: Dec 31
-
Form 24F-2NT RIVERSOURCE OF NEW YORK For: Dec 31
-
Form 8-K Rapport Therapeutics, For: Mar 10
-
Form 24F-2NT RIVERSOURCE OF NEW YORK For: Dec 31
-
Form 8-K ABM INDUSTRIES INC /DE/ For: Mar 10
-
Form 6-K POWERBANK Corp For: Mar 10
-
Form 24F-2NT RIVERSOURCE VARIABLE For: Dec 31
-
Form 24F-2NT RIVERSOURCE ACCOUNT F For: Dec 31
-
Form 10-K Custom Truck One Source, For: Dec 31
-
Form 24F-2NT RIVERSOURCE OF NEW YORK For: Dec 31
-
Form 4/A CERUS CORP For: Mar 05 Filed by: Benjamin Richard J
-
Form 6-K Perion Network Ltd. For: Mar 10
-
Form 8-K Q32 Bio Inc. For: Mar 10
-
Form 24F-2NT RIVERSOURCE LIFE INSURAN For: Dec 31
-
Form 8-K UNITED NATURAL FOODS For: Mar 10
-
Form 8-K Custom Truck One Source, For: Mar 10
-
Form 8-K Apyx Medical Corp For: Mar 10
-
Form 8-K Howmet Aerospace Inc. For: Mar 10
-
Form 8-K Inspired Entertainment, For: Mar 10
-
Form 8-K KOHLS Corp For: Mar 10
-
Form 8-K WILLIS LEASE FINANCE For: Mar 10
-
Form 6-K NIO Inc. For: Mar 10
-
Form 6-K Satellos Bioscience Inc. For: Mar 10
-
Form 6-K Legend Biotech Corp For: Mar 10
-
Form 20-F BioNTech SE For: Dec 31
-
Form S-8 NIO Inc.
-
Form 6-K BioNTech SE For: Mar 10
-
Form 8-K Duke Energy CORP For: Mar 10
-
Form ARS M&T BANK CORP For: Dec 31
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 6-K STANTEC INC For: Mar 10
-
Form 6-K Yalla Group Ltd For: Mar 10
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K Zura Bio Ltd For: Mar 10
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K KB Financial Group Inc. For: Mar 10
-
Form 6-K CHUNGHWA TELECOM CO LTD For: Mar 10
-
Form 6-K Yalla Group Ltd For: Mar 10
-
Form DEFA14A M&T BANK CORP
-
Form 6-K BioNTech SE For: Mar 10
-
Form DEF 14A M&T BANK CORP For: Apr 21
-
Form 8-K Walker & Dunlop, Inc. For: Mar 10
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K NIO Inc. For: Mar 10
-
Form 6-K TAIWAN SEMICONDUCTOR For: Feb 28
-
Form 8-K TransUnion For: Mar 10
-
Form PREC14A Virtus Dividend, Interes Filed by: Saba Capital Management, L.P.
-
Form 8-K Lipocine Inc. For: Mar 10

